This compound was also examined for mu-opioid receptor action, and like conolidine, was identified to acquire no action at the site. Making use of precisely the same paw injection exam, various alternate options with larger efficacy were being found that inhibited the Original suffering response, indicating opiate-like action. Provided the differen